sintilimab Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1 (1)
Phase 2 (1)

Interventional (2)

Innovent Biologics (Suzhou) Co. Ltd. (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadadjuvant therapy

I am/have/hadunstable angina

I am/have/hadlung cancer

I am/have/hadpneumonia

I am/have/hadhepatitis

I am/have/hadneutrophil count

I am/have/hadstroke

I am/have/hadproteinuria

I am/have/hadliver disease

I am/have/haddiabetes

I am/have/hadblood pregnancy test

I am/have/hadinterstitial lung disease

I am/have/hadnon-small cell lung cancer

I am/have/hadcancer

I am/have/hadmyocardial infarction

I am/have/hadmental illness

I am/have/hadtransient ischemic attack

I am/have/hadpulmonary disease

I am/have/hadplatelet count

I am/have/hadsmall cell lung cancer

added new label for I am/have/had

more

I am looking for

I am looking forcolony stimulating factor

I am looking forcarboplatin

I am looking forpaclitaxel

I am looking forg-csf

I am looking forgranulocyte colony stimulating factor

I am looking forsintilimab

I am looking forpemetrexed

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC neoSCORE

This is a Phase 2, prospective, randomized, open-Label, single-center international study that assesses the efficacy and safety of neoadjuvant therapy with different cycles of sintilimab combined with chemotherapy for resectable NSCLC. This trial will also explore the biomarkers of neoadjuvant immunochemotherapy.

adjuvant therapy

unstable angina

lung cancer

pneumonia

hepatitis

0 views
19 Feb, 2024

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Ib Study of the Efficacy and Safety of IBI310 Combined With Sintilimab in Advanced Hepatocellular Carcinoma

An open-label, single-arm, Ib study of the efficacy and safety of IBI310 combined with sintilimab in patients with advanced hepatocellular carcinoma

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.